Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR+, HER2- advanced breast cancer: results from BOLERO-2.
scientific article published on 09 February 2017
Author/s
author:
Josep Baselga,
Gabriel N Hortobagyi,
Sarat Chandarlapaty
Wikidata